Printer Friendly

GLUKOMEDITECH MINIATURIZES IMPLANTABLE GLUCOSE SENSOR.

GlukoMediTech AG, Witten, Germany, a wholly owned subsidiary of Sangui BioTech International Inc. (OTC BB:SGBI) (Berlin: WKN 906757), (SBH.GR -- Bloomberg), (SGBI.D --Reuters), Santa Ana, Calif., has finished the miniaturization of the opto- electronical measuring chamber of the company's long-term implantable glucose sensor.

The measuring chamber has reached its final dimensions now. It has been miniaturized to less than 1/10 of the size of the partly miniaturized device presented at the company's open house held on April 30 and May 1, 1999 at the facilities in Witten. The chamber contains the light source, the cuvette for the measuring sample, the detectors and the optical components.

"We have reached a milestone: At the moment it is not possible to reduce the size of the chamber furthermore because smaller components are not productable or they are not available on the market. Now we focus our efforts on the further miniaturization of the electronical compounds and the telemetric unit," explained Kai Zirk, one of GlukoMediTech's development engineers.

Concerning the exchange system, the company has established contacts with competent business partners to realize its innovative ideas regarding the biological compatibility of the micro-dialyzing system.

"Recently we strengthened the Gluko-team by employing three new people. Therefore we hope to realize our plan to present a prototype of the glucose sensor at the MEDICA fair 1999 in Dusseldorf," said Professor Wolfgang Barnikol M.D., Ph.D., the company's chairman and director.

For more information, call 714/429-7807.
COPYRIGHT 1999 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Biotech Equipment Update
Geographic Code:4EUGE
Date:Oct 1, 1999
Words:244
Previous Article:HP SITE OFFERS ELECTRONIC AND CLASSIC STETHOSCOPES FOR SALE.
Next Article:BD ACQUIRES SAF-T-MED ADVANCED SAFETY NEEDLE TECHNOLOGY.
Topics:


Related Articles
SPECTRX/ABBOTT TO DEVELOP CONTINUOUS GLUCOSE MONITOR.
Implanted glucose monitoring device.
Implanted glucose monitoring device.
Sweet frequency: implantable glucose sensor transmits data wirelessly.
Alfred E. Mann Foundation obtains United States patent.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |